Privo Technologies

Privo Technologies Privo Technologies is a private company spun out of the world-renowned Langer Laboratory at MIT developing a novel new treatment platform for oral cancer.

Privo Technologies is a privately funded company that spun out of the world-renowned Langer Laboratory at the Massachusetts Institute of Technology (MIT) in Cambridge, Massachusetts, USA. Privo is developing a novel, nanotechnology-based drug delivery platform capable of local and systemic delivery of a constant, controlled therapeutic dose through the mucosa. This approach eliminates needles, avo

ids stomach acids, can significantly reduce toxic side effects of drugs, and allows for higher dosing where the drugs can be most effective – all of which improve patient outcomes and compliance. Privo was founded by Manijeh Goldberg who is a seasoned executive with over 20 years experience in the medical industry as an executive leader and a scientist in large and small start-up companies, one of which (Epicon) was acquired for $275M. Her 12 years of large company experience includes working for HP medical and Siemens Medical Systems. Manijeh’s MBA from MIT and MS from Harvard Medical School led to her working with Professor Robert Langer. Professor Langer has global expertise in nanotechnology and drug delivery, and is now an advisor to Privo. Privo is focused on dramatically improving human health through its novel and proprietary Mucosal Delivery Particle (MDP) platform. Privo’s platform has both small and large molecule applications. The technologies used in Privo’s platform have previously received MIT’s prestigious Deshpande Center for Technological Innovation Award as well as an award from MIT’s 100k (Best Product) for work surrounding buccal delivery of insulin.

05/26/2025

🌟 Give Pets with Cancer a Second Chance

Every year, millions of dogs and cats are diagnosed with cancer.
Most families are faced with heartbreaking choices—and far too often, there’s no good option.
That’s why BeneVet Oncology exists.

We develop non-invasive cancer treatments for pets, giving them a chance to live longer, happier lives—without surgery or suffering.

We’ve already treated dogs and cats that no one else would help. Tumors too large. Cases too advanced.
And yet—they wagged their tails again. They played again. They got more time.

💔 1 in 4 dogs will die of cancer.
🙏 With your help, we can change that.

Your donation helps us treat real animals who still have love left to give.
🐶🐱 Every dollar goes toward compassionate-use therapies and expanding access.

📌 Click below to donate now and give pets another chance at life.
Together, we can fight for them.

[🔗 https://www.gofundme.com/f/support-benevet-lifesaving-cancer-treatments-for-pets]

Privo Technologies is a private company spun out of the world-renowned Langer Laboratory at MIT developing a novel new treatment platform for oral cancer.

We’re thrilled to announce the official launch of BeneVet Oncology ( subsidiary of PrivoTechnologies) — a bold new chapt...
05/23/2025

We’re thrilled to announce the official launch of BeneVet Oncology ( subsidiary of PrivoTechnologies) — a bold new chapter in advancing companion animal health through innovation. 🐶🐱
At Privo Technologies, we’ve always believed in transforming lives through science — and with BeneVet, we’re extending that mission to our four-legged family members. From cutting-edge treatments like PRV131 and PRV211 to compassionate care models, we’re bringing hope and healing to the veterinary world.
🔗 Read the full press release here:
https://www.bene-vet.com/

A huge thank you to our amazing team, partners, and the veterinary community. The future of oncology in pets just got brighter. ✨

06/01/2021
Thank you, Lena Elkins, for featuring me in the  SUCCESS magazine.https://lnkd.in/efJy9Tj
04/19/2020

Thank you, Lena Elkins, for featuring me in the SUCCESS magazine.
https://lnkd.in/efJy9Tj

In times of turmoil, let’s not forget that we aren’t alone, and that life is not determined by what’s happening but how we react to it.

Dear All,I'm so excited to share my interview on the popular podcast http://bit.ly/Wings482 with my friend, and 5-time s...
04/09/2020

Dear All,
I'm so excited to share my interview on the popular podcast http://bit.ly/Wings482 with my friend, and 5-time serial entrepreneur Melinda Wittstock today.
Hoping, you can hear a relatable message today in my episode!
I always love talking with Melinda, who focuses on the connections between personal and business growth in starting, growing and scaling your business around the life you want - without tradeoff, guilt or apology.

Hope you and family are well & safe,
Manijeh

We live with them every day, and somehow find it within ourselves to step up, step around, step through, any obstacle in our way.

I am proud of my team for making Privo Technologies successful. We won't sleep until we put cancer to bed.
10/04/2017

I am proud of my team for making Privo Technologies successful. We won't sleep until we put cancer to bed.

NS_October_17_ZMAGS

At the RESI conference in Boston! Privo is proud to serve as both an exhibitor and selected speaker at RESI, and would l...
01/11/2017

At the RESI conference in Boston! Privo is proud to serve as both an exhibitor and selected speaker at RESI, and would like to thank the National Cancer Institute for funding Privo’s inclusion as part of this conference. We look forward to networking with potential investors and entrepreneurs. Check out our poster below!

01/09/2017

Privo Technologies is pleased to announce that the company has just completed a face to face Type B Pre-IND meeting with FDA's Center for Drug Evaluation and Research. This meeting was conducted to answer questions regarding the clinical testing of the Privo's ChemoThin Wafer product, for the treatment of oral cancer. Privo has received encouraging, positive feedback from CDER during this meeting and looks forward to the imminent submission of an IND application.

Privo Technologies is pleased to announce that the company has won the 2016 National Tibbetts award for outstanding cont...
01/09/2017

Privo Technologies is pleased to announce that the company has won the 2016 National Tibbetts award for outstanding contributions to the Small Business Innovation Research (SBIR) program. The SBIR program stated "We are proud to recognize your company’s outstanding work that has contributed so greatly to the success of the SBIR program." Privo would like to congratulate it's team for their hard work and dedication to the company. Privo's CEO and Founder, Dr. Manijeh Goldberg, received this award from the White House on January 10 2017.

Networking at Harvard Club of Boston!
02/17/2016

Networking at Harvard Club of Boston!

At the US patent office. Working to finalize Privo's pending patent applications.
02/10/2016

At the US patent office. Working to finalize Privo's pending patent applications.

Aaron Manzi and Manijeh Goldberg in DC .great meetings with NIH
02/10/2016

Aaron Manzi and Manijeh Goldberg in DC .great meetings with NIH

Address

200 Corporate Place Suite 6B
Peabody, MA
01960

Alerts

Be the first to know and let us send you an email when Privo Technologies posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Privo Technologies:

Share